Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Citi
Daiichi Sankyo
Farmers Insurance
Moodys
US Army
Chinese Patent Office
Fuji

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019926

« Back to Dashboard

NDA 019926 describes HEXALEN, which is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. Additional details are available on the HEXALEN profile page.

The generic ingredient in HEXALEN is altretamine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the altretamine profile page.
Summary for 019926
Tradename:HEXALEN
Applicant:Eisai Inc
Ingredient:altretamine
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 019926
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for 019926
Suppliers and Packaging for NDA: 019926
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HEXALEN altretamine CAPSULE;ORAL 019926 NDA Eisai Inc. 62856-001 N 62856-001-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Dec 26, 1990TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Healthtrust
Farmers Insurance
UBS
Baxter
Moodys
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.